MedPath

The Effect of Negatively Fluid Balancing Speed for ICU Patients With Acute Respiratory Distress Syndrome

Not Applicable
Conditions
Fluid Loss
Registration Number
NCT03552601
Lead Sponsor
Qingdao University
Brief Summary

Previous studies have shown that a positive fluid balance was an independent factor of worse prognosis in ICU patients with acute respiratory distress syndrome (ARDS), and negative fluid balance has been demonstrated to increase oxygenation index, reduce time under mechanical ventilation and ICU length of stay with no noticeable adverse effects. But there is no evidence that faster speed of negative fluid balance would be more beneficial for ARDS patients. So researchers designed the study to prove the effect of negatively fluid balancing speed for ICU patients with ARDS.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
70
Inclusion Criteria

·Patients with ARDS (Berlin 2012 criterion)

Exclusion Criteria
  • Pregnant women
  • Unstable hemodynamics status
  • < 18 years old

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
increased oxygenation index proportion at 24hat the time of 24 hours

Oxygenation index equals arterial oxygen partial pressure/fraction of inspiration O2 (PO2/FIO2). Increased oxygenation index proportion at 24h equals (oxygenation index at 24h - oxygenation index at baseline)/ oxygenation index at baseline.

Secondary Outcome Measures
NameTimeMethod
Duration of free mechanical ventilationup to 28 days

Days when patients are free of mechanical ventilation

Oxygenation index every dayup to 7 days

oxygenation index equals arterial oxygen partial pressure/fraction of inspiration O2 (PO2/FIO2).

mortalityup to 28 days

a measure for the rate at which deaths occur in a given population

Trial Locations

Locations (1)

The affiliated hospital of qingdao university

🇨🇳

Qingdao, Shandong, China

The affiliated hospital of qingdao university
🇨🇳Qingdao, Shandong, China
BO YAO, PHD
Contact
+86 053282912221
icuyaobo@126.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.